The Chester Pierce Research Society (CPRS) is an annual speaker series named in honor of the late Professor Emeritus in Psychiatry Chester Pierce, MD, the first African-American physician-scientist and full professor at Mass General. CPRS exposes the Mass General community to novel basic science, clinical, translational, health services and disparities research by our talented URM physicians and scientists.

Upcoming Speaker Series

July 27, 2021

5 pm–6 pm
To RSVP, please email cdi@mgh.harvard.edu.

"Clinical Translation of Genetic Predictors for Type 2 Diabetes"

Speaker:

Jose Florez, MDJose Florez, MD
Department of Medicine, Diabetes Unit
Chief, Endocrine Division and Diabetes Unit
Professor of Medicine, Harvard Medical School
Institute Member, Broad Institute

Dr. Florez is the Chief of the Endocrine Division and the Diabetes Unit at the MGH, where he holds the John T. Potts Jr., MD Endowed Chair in Medicine. He is also Professor of Medicine at Harvard Medical School, and an Institute Member at the Broad Institute. He and his group have contributed to the performance and analysis of high-throughput genomic studies in type 2 diabetes and related traits, in international consortia such as MAGIC, GENIE, DIAGRAM, T2D-GENES, AMP-T2D, SIGMA and RADIANT, where he plays management roles. He leads the genetics initiatives of the Diabetes Prevention Program and the GRADE clinical trial, where the effects of genetic variants on specific behavioral and pharmacological preventive interventions can be assessed. He is the Principal Investigator of the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH), and also conducts other pharmacogenetic studies at MGH. He is an author on 200+ original publications and 50+ reviews/book chapters. In addition to his research and teaching duties, he is clinically active in the MGH Diabetes Center, the Endocrine inpatient consult service, and the MGH Down Syndrome Program. In 2007 he received an MGH Physician-Scientist Development Award (PSDA) and he is a recipient of the 2010 Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers. In 2019 he received the Father of the Year award from the American Diabetes Association.

October 22, 2021

12 pm–1 pm

"Obesity in Pediatrics: Our Understanding and Consideration of Pharmacologic and Surgical Treatment Approaches"

Speaker:

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS (bio)
Obesity Medicine Physician for Adults, Adolescents, and Children, MGH Weight Center
Director of Equity, MGH Medicine–Endocrine Division
Director of Diversity, Nutrition Obesity Research Center at Harvard (NORCH)
CoreFaculty, MGH Mongan Institute of Health Policy
Leadership Team, MGH Midlife Women’s Health Center
Assistant Professor–Medicine & Pediatrics, Harvard Medical School

RSVP to the event (link coming soon)

Previous Speaker Series

2019 Lecture: Why Do So Many Black People Have Kidney Disease? Insights from Human Stem Cell-Derived Podocytes

Opeyemi Olabisi, MD, PhD
2019 Speaker Opeyemi Olabisi, MD, PhD

2019 speaker Opeyemi Olabisi, MD, PhD, is a physician in the Nephrology Division of the Mass General Department of Medicine and Assistant Professor of Medicine at Harvard Medical School. Dr. Olabisi graduated in 2001 from The City College of New York with a bachelor’s degree in Biology and received his MD, PhD degree in 2009 from Albert Einstein College of Medicine, where he studied the regulation of the NFAT transcription factor. He came to Mass General in 2009, completed a residency in internal medicine, and subsequently completed a fellowship in the combined Mass General-Brigham & Women's nephrology fellowship program. Dr. Olabisi recognizes that an effective approach to reducing the mortality associated with chronic kidney disease (CKD) is to reduce the rate of progression of CKD to end stage kidney disease (ESKD). This passion motivates his ongoing research of the mechanism by which mutations in ApoL1 gene accelerate progression of CKD to ESKD. Early in 2015, he joined the Faculty of Renal Division in Mass General Department of Medicine. In support of his work, Dr. Olabisi recently received the 2015 Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation.

2017 Lecture: Overcoming Immunosuppression to Treat Malignant Brain Tumors

William T. Curry, Jr., MD
2017 Speaker William T. Curry, Jr., MD

On July 6, 2017, William T. Curry, Jr., MD delivered the CPRS lecture titled “Overcoming Immunosuppression to Treat Malignant Brain Tumors.” Dr. Curry conducts translational research in immunotherapy for malignant brain tumors. One current focus is on achieving representative ethnic diversity in cancer clinical trials and understanding ethnic variations in biological responses to therapies. Early in his career, he was awarded the 2006 Physician/Scientist Development Award, which helped support his translational research focus. Dr. Curry is the first African American full professor in Neurosurgery at Mass General. He is the director of Neurosurgical Oncology with a clinical practice that focuses on caring for patients with benign and malignant tumors of the brain and cranial base.